Children
Sign in to add traineeChong Chen | grad student | 2009 | University of Michigan (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Muthana MM, Du X, Liu M, et al. (2023) CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment. Elife. 12 |
Muthana MM, Du X, Liu M, et al. (2023) CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment. Biorxiv : the Preprint Server For Biology |
Liu Y, Zheng P. (2019) Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. Trends in Pharmacological Sciences |
Liu Y, Zheng P. (2019) Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. Trends in Pharmacological Sciences |
Paluskievicz CM, Cao X, Abdi R, et al. (2019) T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology. 10: 2453 |
Paluskievicz CM, Cao X, Abdi R, et al. (2019) T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology. 10: 2453 |
Tao R, Murad N, Xu Z, et al. (2019) MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research |
Tao R, Murad N, Xu Z, et al. (2019) MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research |
Du X, Tang F, Liu M, et al. (2018) A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research |
Du X, Tang F, Liu M, et al. (2018) A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research |